Ceuta Group Welcomes Ex HRA Pharma’s CEO David Wright As Non-Executive Board Director

David Wright has been appointed as a non-executive board director at Ceuta Group.

With extensive experience of leading global consumer healthcare companies, David joins Ceuta Group following five years as CEO/President of global pharmaceutical company, HRA Pharma and six years as Global Head of Boehringer Ingelheim’s consumer business.

During his time at HRA Pharma and Boehringer Ingelheim GmBH, David led both companies through substantial organisational and strategy re-design which led to sustainable growth and profitability.

David has a strong belief that combining the right structure, operational priorities and processes, with a strong focus on company culture, are critical factors in building successful businesses. This approach saw him lead a period of transformation at HRA Pharma resulting in the company’s successful acquisition by Perrigo Company plc.

Bringing to Ceuta Group broad international experience having led multinational businesses in the USA, Japan, Germany and France, David will help further establish Ceuta Group’s global presence and support its untapped potential.

Commenting on his new role, David said, “Having worked with Ceuta Group while I was at Boehringer and HRA Pharma, I have first hand experience of how it can deliver maximum impact for clients at all stages of growth development. I’m excited to be joining Ceuta Group at this pivotal time and look forward to being a part of its continued success and growth.”

David will take an active role on the Ceuta Group Board supporting and building the company’s strategic vision and priorities. He will also help shape the company’s growth plans on an operational level to ensure Ceuta Group continues to meet client’s needs today and into the future.

Edwin Bessant, Ceuta Group CEO, said on behalf of the Board, “David brings extensive global corporate and industry experience and insight to Ceuta Group.

“He has delivered exceptional commercial outcomes in previous roles and we’re absolutely delighted to have him join Ceuta Group as a non-executive board director. His ability to grow successful businesses and teams across the globe will be significant to the future growth of Ceuta Group.”

To find out more about how to unlock the true potential of your brand, get in touch.

Contact us

Related Content


Ceuta Group joins the Consumer Healthcare Products Association (CHPA)


Thinking outside the box — Key take-aways from Annette D’Abreo’s interview with P3Pharmacy magazine


Ceuta Group appoints David Skinner as Chief Financial Officer

Three people from Ceuta Group sit in a podcast recording studio around a table smiling

Episode 01 | Creating Supplier-Retailer Synergy for Growth in the Ever-Changing Health & Wellness Industry